Companies / Kinnate Biopharma Inc.
Kinnate Biopharma Inc.
KNTECIK 1797768
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 8, 2023 | Foresite Capital Management IV, LLC +1 co-filer 10% owner | Buy Open-market buy | Common Stock | $4.34M | +1.6M +78.53% | 3,525,957 | high |
| Feb 11, 2022 | Orbimed Advisors LLC +1 co-filer Director | Buy Open-market buy | Common Stock | $1.59M | +156K +4.71% | 3,469,330 | high |
| May 5, 2023 | Gordon Carl L +1 co-filer Director | Buy Open-market buy | Common Stock | $1.38M | +491K +55.88% | 1,368,339 | high |
| May 5, 2023 | Gordon Carl L +1 co-filer Director | Buy Open-market buy | Common Stock | $1.38M | +491K +55.88% | 1,368,338 | high |
| May 1, 2023 | Orbimed Advisors LLC +1 co-filer Director | Buy Open-market buy | Common Stock | $1.22M | +467K +12.50% | 4,204,852 | high |
| May 4, 2023 | Gordon Carl L +1 co-filer Director | Buy Open-market buy | Common Stock | $860.7K | +313K +7.07% | 4,738,453 | high |
| May 8, 2023 | Foresite Capital Management IV, LLC +1 co-filer 10% owner | Buy Open-market buy | Common Stock | $641.3K | +229K +78.53% | 520,711 | high |
| May 2, 2023 | Orbimed Advisors LLC +1 co-filer Director | Buy Open-market buy | Common Stock | $589.0K | +221K +5.25% | 4,425,462 | high |